| | | | | | | |

Irradiating Procedure Tracts Reduces Metastatic Mesothelioma in New Study

ByAlex Strauss

metastatic pleural mesotheliomaIrradiating the tracts through which certain interventions are performed can reduce the risk of metastatic pleural mesothelioma. That word comes from a new study in Singapore. 

The pleural form of malignant mesothelioma occurs on the lining around the lungs. Doctors often have to insert tools through the chest wall for diagnosis or treatment. The paths or tracts along which they insert those tools can be the site of new mesothelioma tumors. 

But the study shows that timely radiation treatment of those paths may prevent metastatic pleural mesothelioma.

Metastatic Pleural Mesothelioma

Metastasis is when cancer cells move from their original site to another place in the body. A tumor that is contained in one spot is easier to treat or remove. Metastatic pleural mesothelioma is harder to treat. When cancer spreads, the odds of survival go down. 

One goal of mesothelioma treatments like chemotherapy and surgery is to keep mesothelioma from spreading. Ironically, some procedures that are necessary to diagnose or treat mesothelioma symptoms can end up promoting metastatic pleural mesothelioma. 

Inserting a needle through the chest wall to drain excess chest fluid is an example. Many mesothelioma patients experience a build-up of fluid around the lungs as their cancer grows. Doctors can draw off some of that fluid – and reduce symptoms like shortness of breath – by inserting a needle or catheter through the chest wall. 

When the needle or catheter is withdrawn, it may take a few mesothelioma cells with it. These cells can turn into metastatic mesothelioma along that tract. Radiation right after the procedure might help keep this from happening. 

Prophylactic Irradiation of Procedure Tracts

Prophylactic irradiation is when doctors use radiation on an area before any tumor has formed there. The goal is to destroy those “seed” cells before they can give rise to metastatic pleural mesothelioma. 

To see how well this approach works, researchers in Singapore analyzed five clinical trials on prophylactic irradiation of tracts (PIT). The trials included 737 patients with pleural mesothelioma. 

“PIT significantly reduces the occurrence of procedure tract metastases in patients with malignant pleural mesothelioma who had a diagnostic or therapeutic chest wall procedure,” writes investigator Chia Ching Lee of National University of Singapore.

Not everyone agrees with this assessment, though. A 2019 UK study of 375 patients found that PIT did not reduce the incidence of metastatic pleural mesothelioma. In that study, more than 60 percent of patients who had PIT develop radiation dermatitis as a result. 

Mesothelioma patients having a procedure that pierces the chest wall may want to explore the pros and cons of prophylactic radiation with their doctor. 

Sources:

Lee, CC, et al, “Prophylactic Irradiation of Tracts in Patients with Malignant Pleural Mesothelioma: A Systematic Review and Meta-analysis of Randomized Trials”, March 3, 2021, Critical Reviews in Oncology and Hematology, Online ahead of print, https://www.sciencedirect.com/science/article/abs/pii/S1040842821000664?via%3Dihub

Bayman, N, et al, “Prophylactic Irradiation of Tracts in Patients With Malignant Pleural Mesothelioma: An Open-Label, Multicenter, Phase III Randomized Trial”, March 2019, Journal of Clinical Oncology, https://ascopubs.org/doi/10.1200/JCO.18.01678

Similar Posts

  • | |

    Mesothelioma survivor Paul Kraus, alive and well 19 years after writing “Surviving Mesothelioma and Other Cancers

    ByAlex Strauss

    Paul Kraus is considered the longest documented mesothelioma survivor in the world. He was diagnosed in 1997 with mesothelioma so widespread that he was given little hope of survival. Not willing to give up, he worked with a team of doctors to create his own tailored treatment protocol. This protocol included dramatic life style change, experimental therapies, dietary changes, mind-body medicine, and other modalities. Paul was fortunate. The protocol he and his doctors created helped him keep the mesothelioma in check. His book “Surviving Mesothelioma and Other Cancers: A Patient’s Guide” details his cancer voyage, the decisions he made, and his philosophies about health and healing. This book is now the best-selling mesothelioma book in the world and has inspired…

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    ByAlex Strauss

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    ByAlex Strauss

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    ByAlex Strauss

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    ByAlex Strauss

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    ByAlex Strauss

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…